Axios @axios
Sanofi and GSK announced this morning their COVID-19 vaccine candidate demonstrated a strong immune response in adults in a phase 2 clinical trial. https://t.co/jQW6Ai1J3t — PolitiTweet.org
Created
Mon May 17 13:15:32 +0000 2021
Likes
32
Retweets
18
Source
TweetDeck
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
Sanofi and GSK announced this morning their COVID-19 vaccine candidate demonstrated a strong immune response in adults in a phase 2 clinical trial. https://t.co/jQW6Ai1J3t — PolitiTweet.org